Picornaviridae · Enterovirus
| Azithromycin | EV-A71 | — | Preclinical | — | Human (multiple) | |
| Berberine | EV-A71 | AMP-activated protein kinase (AMPK) activator | Preclinical | — | Unknown | |
| Camptothecin | EV-A71 | Topoisomerase I inhibitor | Preclinical | — | Human topoisomerase | |
| Chloroquine | EV-A71 | Antimalaria agent; chemo/radio sensitizer | Preclinical | — | Human (multiple) | |
| Cucurbit[7]uril | EV-A71 | Competitive binding of polyamines | Preclinical | — | Human polyamines | |
| Dibucaine | EV-A71 | — | Preclinical | — | Human (multiple) | |
| Emodin | EV-A71 | — | Preclinical | — | Human (multiple) | |
| Fludarabine | EV-A71 | Purine analog | Preclinical | — | Viral RNA pol | |
| Formoterol | EV-A71 | — | Preclinical | — | Unknown | |
| Gemcitabine | EV-A71 | Antimetabolite; Nucleoside analog | Preclinical | — | Viral RNA pol | |
| Glycyrrhizin | EV-A71 | — | Preclinical | — | Human TNF | |
| Inosine (Inosine pranobex) | EV-A71 | Stimulates cell-mediated immune response | Preclinical | — | Viral RNA pol | |
| Itraconazole | EV-A71 | Inhibition of OSBP and ORP4; Inhibition of viral organelle formation | Preclinical | — | Human lipid transfer protein | |
| Lanatoside C | EV-A71 | Increasing the concentration of intracellular calcium | Preclinical | — | Unknown | |
| Luteolin | EV-A71 | Unknown | Preclinical | — | Unknown | |
| Oseltamivir | EV-A71 | Viral neuraminidase inhibitor | Approved (other) | JapanChina | Unknown | |
| Pentosan polysulfate | EV-A71 | — | Preclinical | — | Human FGF | |
| Quinacrine | EV-A71 | — | Preclinical | — | Viral glycoprotein | |
| Resveratrol | EV-A71 | Multiple | Preclinical | — | Human multiple; Viral transcriptional regulator | |
| Rupintrivir | EV-A71 | Prevents viral replication | Preclinical | — | Viral protease | |
| Simeprevir | EV-A71 | Recovers host IFN signaling | Approved (other) | Japan | Viral protease | |
| Sorafenib | EV-A71 | B-Raf; FGFR-1; VEGFR-2 & -3; PDGFR-beta; KIT; and FLT3 inhibitor | Preclinical | — | Human PTK | |
| Suramin | EV-A71 | Unclear | Preclinical | — | Human (multiple) | |
| Vesatolimod | EV-A71 | Stimulates cell-mediated immune response | Preclinical | — | Human TLR7 |